Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease

American Journal of Psychiatry

Volumn 156, Issue 7, 1999, Pages 1024-1028

  Nelson, J Craig ^a,b,c   Kennedy, John S ^a,b   Pollock, Bruce G ^a,b   Laghrissi Thode, Fouzia ^a,b   Narayan, Meena ^a,b   Nobler, Mitchell S ^a,b   Robin, Deborah W ^a,b   Gergel, Ivan ^a,b   McCafferty, James ^a,b   Roose, Steven ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NORTRIPTYLINE; PAROXETINE;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MYOCLONUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SINUS TACHYCARDIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, TRICYCLIC; COMORBIDITY; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0033012352     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Glassman AH, Shapiro PA: Depression and the course of coronary artery disease. Am J Psychiatry 1998; 155:4-11
2. Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW: Depression, psychotropic medication, and risk of myocardial infarction. Circulation 1996; 94:3123-3129
3. Frazure-Smith N, Lesperance F, Talajic M: Depression following myocardial infarction: impact on 6-month survival. JAMA 1993;270:1819-1825
4. Roose SP, Glassman AH, Attia E, Woodring S: Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994; 151:1735-1739
5. Glassman AH, Roose SP, Bigger JT Jr: The safety of tricyclic antidepressants in cardiac patients: risk/benefit reconsidered. JAMA 1993; 269:2673-2675
6. Roose SP, Glassman AH, Attia E, Woodring S, Giardina E-GV, Bigger JT Jr: Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry 1998; 155:660-665
7. Ray WA, Griffin MR, Avorn J: Evaluating drugs after their approval for clinical use. N Engl J Med 1993; 329:2029-2032
8. Roose SP, Glassman AH, Giardina E-GV, Johnson LL, Walsh BT, Woodring S, Bigger JT Jr: Nortriptyline in depressed patients with left ventricular impairment. JAMA 1986; 256:3253-3257
9. Roose SP, Glassman AH, Siris SG, Walsh BT, Bruno RL, Wright LB: Comparison of imipramine- and nortriptyline-induced orthostatic hypotension: a meaningful difference. J Clin Psychopharmacol 1981; 1:316-319
10. Thayssen P, Bjerre M, Kragh-Sorenson P, Moller M, Petersen OL, Kristensen CB, Gram LF: Cardiovascular effect of imipramine and nortriptyline in elderly patients. Psychopharmacology (Berl) 1981; 74:360-364
11. American Psychiatric Association Task Force on the Use of Laboratory Tests in Psychiatry: Tricyclic antidepressants -blood level measurements and clinical outcome: an APA task force report. Am J Psychiatry 1985; 142:155-162
12. Nelson JC: Importance of intent-to-treat response rates for the clinician. Psychiatr Annals 1996; 26:8-18
13. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
14. Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT Jr, Pollock BG, Gaffney A, Narayan M, Finkel MS, McCafferty J, Gergel I: A comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998;279:287-291
15. 1-adrenergic function (abstract). Biol Psychiatry 1991; 29(suppl):132A
16. Glassman AH, Bigger JT Jr: Cardiovascular effects of therapeutic doses of tricyclic antidepressants. Arch Gen Psychiatry 1981;38:815-820
17. Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, Lepper M, Schoenberger JA, Lindberg HA: Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980; 112:736-749
18. Kannel WB, Kannel C, Paffenberger RS Jr, Cupples LA: Heart rate and cardiovascular mortality: the Framingham study. Am Heart J 1987; 113:1489-1494
19. Gillum RF, Makuc DM, Feldman JJ: Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 1991; 121:172-177